A 6 month prospective, randomized, double blind, placebo-controlled, parallel group, multiple centre trial to evaluate the efficacy and safety of fragmin in the treatment of chronic neuroischaemic foot ulcers in diabetic patients - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: A 6 month prospective, randomized, double blind, placebo-controlled, parallel group, multiple centre trial to evaluate the efficacy and safety of fragmin in the treatment of chronic neuroischaemic foot ulcers in diabetic patients

Funder
Pfizer Ltd

Principal Investigator

Harding, Keith

Project Details

Net value award figure for Cardiff University: £15,000.00

Start date: 17/06/2008

End date: 31/12/2010

Our policy towards the use of cookies